Apatinib in the Treatment of Recurrence or Metastasis of Esophageal Cancer
Clinical trial NCT03913182 · UNKNOWN
Trial details
- NCT number
- NCT03913182
- Sponsor
- Shanghai Chest Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-02
- Primary completion
- 2020-05-30
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.